July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Primary cilia deficiency in neural crest cells leads to Anterior Segment Dysgenesis (ASD) by disruption of the Indian Hedgehog signaling pathway in the periocular mesenchyme
Author Affiliations & Notes
  • Céline Portal
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Qing Liu
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Peter Y Lwigale
    BioSciences, Rice University, Houston, Texas, United States
  • Carlo Iomini
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
    Cell, Development and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Céline Portal, None; Qing Liu, None; Peter Lwigale, None; Carlo Iomini, None
  • Footnotes
    Support  NIH/NEI EY022639, the Research to Prevent Blindness Unrestricted Grant and Dolly Green Special Scholar Award to C.I.
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4154. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Céline Portal, Qing Liu, Peter Y Lwigale, Carlo Iomini; Primary cilia deficiency in neural crest cells leads to Anterior Segment Dysgenesis (ASD) by disruption of the Indian Hedgehog signaling pathway in the periocular mesenchyme. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4154.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Anterior segment dysgenesis (ASD) represents one of the main causes of congenital opacity and leads to glaucoma in ~50% of the cases. Several ciliopathies display conditions affecting tissues of the anterior segment (AS) of unknown pathogenesis. Here we test the hypothesis that assembly of primary cilia in neural crest cells (NCC), from which most of the AS tissue derives, is required for normal AS development.

Methods : We utilize mouse genetics tools to inactivate genes or to detect hedgehog activity in the NCC. Phenotypic analysis of AS in ciliary mutants was assessed on eye sections of paraffin or plastic embedded tissue. Cell proliferation in the periocular mesenchyme (POM) was assessed by bromodeoxyuridine labeling. Components of the Hedgehog (Hh) pathway such as cilia and Smoothened (Smo) as well as nerves and blood vessels were detected by immunostaining. Gene expression was assessed by RT-qPCR on dissected eye tissues or FACS sorted cells using genetically activable fluorescent markers.

Results : Because somatic mutations of ciliogenic genes, including IFT88, lead to midgestation death, we obtained Wnt1-Cre;Ift88fx/fx conditional mutants by ablating IFT88 in NCC. The disruption of primary cilia in the NCC leads to significant reduction of the anterior chamber and cornea diameter, thinner stroma thickness with abnormal keratocytes, reduced mesenchymal cell accumulation at the iridocorneal angle, disorganized corneal innervation and corneal neovascularization. Gene expression analysis revealed reduction of Hh target genes, as well as genes encoding for transcription factors linked to the Axenfeld-Rieger Syndrome, like Pitx2 and Foxc1. By using a reporter mouse (Gli1-LacZ) we show a dramatic reduction of the Hh activity and cell proliferation in POM cells surrounding the optic nerve and the retinal pigmented epithelium including the iridocorneal angle area in cilia mutants. Importantly, ablation of Smo in the NCC leads to a similar but more severe AS phenotype compared to the one observed in cilia mutants. Finally, we show that the main activator of the Hh pathway in the POM is Indian Hh.

Conclusions : Primary cilia play a pivotal role in AS development by promoting the Hh signaling in a subset of POM cells and are involved in the etiology of ocular disorders derived from ASD.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×